Project Details
Description
An extension of the Vermeer study: An open label SLV308 safety extension to study S308.3.003 in early PD patients (Protocol S308.3.008)
Status | Finished |
---|---|
Effective start/end date | 10/15/07 → 10/13/09 |
Funding
- IQVIA, INC
- SOLVAY PHARM